132 related articles for article (PubMed ID: 10669700)
1. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention.
Harwell JI; Brown RB
Chest; 2000 Feb; 117(2):530-41. PubMed ID: 10669700
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
Jacobs MR
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
[TBL] [Abstract][Full Text] [Related]
3. [Increasing antibiotic resistance of pneumococcus. Management of respiratory tract infections and meningitis].
Kalin M; Eriksson M; Mölstad S; Prellner K
Lakartidningen; 1997 Mar; 94(12):1061-4, 1067-8. PubMed ID: 9121238
[No Abstract] [Full Text] [Related]
4. Drug-resistant Streptococcus pneumoniae.
Campbell GD; Silberman R
Clin Infect Dis; 1998 May; 26(5):1188-95. PubMed ID: 9597251
[TBL] [Abstract][Full Text] [Related]
5. The emergence of resistant pneumococcus as a pathogen in childhood upper respiratory tract infections.
Kaplan SL
Semin Respir Infect; 1995 Mar; 10(1):31-6. PubMed ID: 7761712
[TBL] [Abstract][Full Text] [Related]
6. The incidence of penicillin-resistant pneumococci in the Slovak Republic. Pneumococcus Study Group.
Trupl J; Hupková H; Appelbaum PC; Jacobs MR
Chemotherapy; 1997; 43(5):316-22. PubMed ID: 9309364
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus pneumoniae respiratory tract infections.
Klugman KP; Feldman C
Curr Opin Infect Dis; 2001 Apr; 14(2):173-9. PubMed ID: 11979129
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Synergy Between Antibiotics and Pulmonary Toll-Like Receptor 5 Stimulation in Antibiotic-Sensitive or -Resistant Pneumonia.
Matarazzo L; Casilag F; Porte R; Wallet F; Cayet D; Faveeuw C; Carnoy C; Sirard JC
Front Immunol; 2019; 10():723. PubMed ID: 31024555
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
Nuermberger EL; Bishai WR
Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371
[TBL] [Abstract][Full Text] [Related]
10. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
Lynch JP; Zhanel GG
Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
[TBL] [Abstract][Full Text] [Related]
11. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
Chiou CC; Hseih KS
Acta Paediatr Taiwan; 2003; 44(2):67-74. PubMed ID: 12845845
[TBL] [Abstract][Full Text] [Related]
13. Invasive antibiotic-resistant Streptococcus pneumoniae in children in Madrid.
Ramos JT; Saavedra J; Ruiz-Contreras J; Bravo J; Sanz F; Noriega AR
Pediatr Infect Dis J; 1998 Mar; 17(3):252-5. PubMed ID: 9535258
[No Abstract] [Full Text] [Related]
14. Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.
Fuller JD; McGeer A; Low DE
Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):780-8. PubMed ID: 16344922
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary.
Nagy E; Marton A; Hajdú E
Acta Microbiol Immunol Hung; 2003; 50(2-3):119-24. PubMed ID: 12894483
[TBL] [Abstract][Full Text] [Related]
16. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece.
Maraki S; Mantadakis E; Samonis G
Chemotherapy; 2010; 56(4):325-32. PubMed ID: 20720416
[TBL] [Abstract][Full Text] [Related]
17. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
Friedland IR; McCracken GH
N Engl J Med; 1994 Aug; 331(6):377-82. PubMed ID: 8028618
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and antimicrobial resistance of Streptococcus pneumoniae in France in 2007: data from the pneumococcus surveillance network.
Kempf M; Baraduc R; Bonnabau H; Brun M; Chabanon G; Chardon H; Croizé J; Demachy MC; Donnio PY; Dupont P; Fosse T; Gibel L; Gravet A; Grignon B; Hadou T; Hamdad F; Joly-Guillou ML; Koeck JL; Maugein J; Péchinot A; Ploy MC; Raymond J; Ros A; Roussel-Delvallez M; Segonds C; Vergnaud M; Vernet-Garnier V; Lepoutre A; Gutmann L; Varon E; Lanotte P
Microb Drug Resist; 2011 Mar; 17(1):31-6. PubMed ID: 20809835
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, control and treatment of multiresistant pneumococci.
Klugman KP
Drugs; 1996; 52 Suppl 2():42-6. PubMed ID: 8869835
[No Abstract] [Full Text] [Related]
20. Drug-resistant Streptococcus pneumoniae infections: clinical importance, drug treatment, and prevention.
Kellner JD
Semin Respir Infect; 2001 Sep; 16(3):186-95. PubMed ID: 11562898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
